Skip to main content
L&C BIO Co., Ltd logo

L&C BIO Co., Ltd — Investor Relations & Filings

Ticker · 290650 ISIN · KR7290650001 KO Manufacturing
Open in API
Filings indexed 378 across all filing types
Latest filing 2025-12-16 Notice of Dividend Amou…
Country KR South Korea
Listing KO 290650

About L&C BIO Co., Ltd

http://www.lncbio.co.kr/?locale=en_US

L&C BIO Co., Ltd. is a biotechnology company specializing in regenerative medicine. The company develops, manufactures, and commercializes human tissue-based medical devices and allograft treatment materials. Its core operations include the processing, storage, and distribution of human tissues, with a focus on skin, musculoskeletal, and soft tissues, utilizing patented processing technologies. The company's product portfolio also extends to other medical devices and cosmetics. L&C BIO supports its activities through dedicated research and development centers and manufacturing facilities, including a human tissue plant and a pharmaceutical plant, to advance its pipeline and serve global markets.

Recent filings

Filing Released Lang Actions
주주명부폐쇄기간또는기준일설정
Notice of Dividend Amount Classification · 95% confidence The document is a short regulatory announcement regarding the setting of a record date and shareholder register closure for the purpose of an upcoming Annual General Meeting (AGM). It does not contain the full meeting materials or proxy statements, but rather serves as a formal regulatory notice of the administrative procedure for the meeting. As it is a standard regulatory announcement that does not fit into specific categories like 'AGM-R' (which implies presentation materials) or 'PSI' (which implies proxy solicitation materials), it is best classified as a general regulatory filing.
2025-12-16 Korean
현금ㆍ현물배당결정
Notice of Dividend Amount Classification · 100% confidence The document is a formal announcement from L&C Bio regarding a decision to pay cash dividends. It specifies the dividend amount per share, the total dividend amount, the record date, and the approval process. This fits the definition of a 'Notice of Dividend Amount' (DIV).
2025-12-16 Korean
[기재정정]기타경영사항(자율공시) (MegaShield®SP (메가쉴드®SP)의 척추 수술 후 유착 방지 효과 및 안전성에 대한 임상시험계획(IND) 승인)
Regulatory Filings Classification · 95% confidence The document is a regulatory announcement regarding the approval and extension of a clinical trial plan (IND) for a medical device product. It includes details about the clinical trial's purpose, duration, and approval dates, but does not contain financial statements, earnings data, or detailed management discussion. The document is relatively short (2433 characters) and serves as a disclosure of a business matter (clinical trial approval and extension) rather than a financial report or detailed management report. It fits best under 'Regulatory Filings' (RNS) as a general regulatory announcement and voluntary disclosure about business activities, not a formal financial or management report.
2025-11-11 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is titled '주식등의 대량보유상황보고서(일반)' which translates to 'Report on Large Shareholding Status (General)'. It contains detailed information about the number of shares held, changes in shareholding, related contracts, and the relationship between the reporting person and the company. It references specific dates and shareholding percentages, and it is clearly a regulatory filing related to disclosure of major shareholdings. There is no indication that this is an announcement of a report publication, nor is it a financial report or management report. The content matches the definition of a Major Shareholding Notification, which is a notification of changes in significant share ownership levels (crossing thresholds). Therefore, the correct classification is MRQ (Major Shareholding Notification). The document length and detail support a high confidence score.
2025-10-28 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 94% confidence The document is a disclosure titled “임원ㆍ주요주주 특정증권등 소유상황보고서,” detailing the share ownership and changes (acquisitions/disposals) by an officer (Kim Ki-Min). It is an insider/share transaction report by a company director, fitting the Director’s Dealing category.
2025-09-26 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 92% confidence The document is a “주식등의 대량보유상황보고서” (Report on Large Shareholding Positions) filed under Korean capital markets law, detailing the number of shares held, changes in holdings, reporting dates, reporting persons and related contracts. This matches the definition of a Major Shareholding Notification (Code: MRQ), reporting significant share ownership changes beyond regulatory thresholds. It is neither an AGM material, financial report, nor simple announcement but a regulatory shareholding disclosure.
2025-09-26 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.